Application no. and date | 10710748.4 (espacenet) (Federated) (European Patent Register), 20100319 | Patent/reg. no. and date | DK/EP 2408749, 20180516 | Publication date | 20120125 | Priority no. and date | US 162130 P, 20090320 | EP pub. no. and date |
EP 2408749 20120125 | Effective date | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | Applicant ref. no. | P65575DK01 | Inventor | GROOTENHUIS, Peter, D.J., 4801 Riding Ridge Road
San Diego CA 92130, US, YANG, Xiaoqing, 4526 Vereda Mar De Ponderosa
San Diego CA 92130, US, HADIDA RUAH, Sara, S., 2356 Torrey Pines Road, 16
La Jolla CA 92037, US, VAN GOOR, Fredrick, F., 832 Ormond Court
San Diego CA 92109, US, BOTFIELD, Martyn, C., 47 Walden Terrace
Concord MA 01742, US, ZLOKARNIK, Gregor, 2754 Palomino Circle
La Jolla CA 92037, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/47 (2006.01) , A61P 3/00 (2006.01) , C07D 215/233 (2006.01) | Title | MODULATORER AF CYSTISK FIBROSE-TRANSMEMBRAN-KONDUKTANSREGULATOR | Int. application no. | US2010028062 | Int. publication no. | WO2010108155 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|